Automated description from the Alliance of Genome Resources
Predicted to have RNA polymerase II proximal promoter sequence-specific DNA binding activity. Involved in several processes, including innate immune response; negative regulation of NF-kappaB transcription factor activity; and negative regulation of type I interferon-mediated signaling pathway. Localizes to the cytosol and nucleus. Predicted to colocalize with the cytoplasm. Orthologous to human NLRC5 (NLR family CARD domain containing 5).